← Evidence map

ArticleDer Nervenarzt2012

[Alemtuzumab: a further option for treatment of multiple sclerosis].

T Menge et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 22038387